Trial site
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
- 10running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Multiple myeloma3 trials
- Bladder cancer2 trials
- Childhood cancers2 trials
- Melanoma2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- and 2 more
- Phase
- Phase 34 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Recruiting5 trials
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer3 trials
- Amgen2 trials
- Janssen Research & Development, LLC2 trials
- Bristol-Myers Squibb1 trial
- Fujifilm Pharmaceuticals U.S.A., Inc.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
Active, not recruiting
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma2 recruiting
- Bladder cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026